ÂÜÀòÂÒÂ×

Qing Zhu is a highly experienced professional in the field of biopharmaceutical research, currently serving as the Head of China R&D and SVP at Brii Biosciences since May 2018. Prior to this role, Qing Zhu held the position of Director in the R&D Department of Infectious Diseases and Vaccines at MedImmune from August 2007 to March 2018. Experience also includes roles as Research Scientist II at Novartis Vaccines and Research Scientist at Chiron Corporation, focusing on pharmacology and translational sciences. Qing Zhu completed a Postdoctoral Fellowship in Molecular Virology at Fox Chase Cancer Center and earned a Ph.D. in Molecular and Cell Biology from the University of Maryland, Baltimore Graduate School.